Literature DB >> 6849801

The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.

J M Howat, D M Barnes, M Harris, R Swindell.   

Abstract

Two hundred and eighty-eight primary breast tumours were examined for the presence or absence of oestrogen (REc) and progesterone (RPc) receptors. Analysis has shown a relative interdependence between the steroid receptor status of primary breast cancer and other prognostic variables such as histological grade, lymphocytic infiltration and tumour elastosis. There were significant associations between epithelial cellularity, stromal fibrosis and the value of REc in those tumours in which the receptor was present. Cellularity and fibrosis were unrelated to the presence or absence of oestrogen receptor. By contrast, neither the presence or absence nor the value of RPc could be related to cellularity or fibrosis. The value of REc and RPc analysis as an indicator of prognosis was examined in a sub-group of 175 patients receiving no additional treatment following mastectomy. Overall relapse-free survival (RFS) was no different for those patients with receptors compared to those without them (REc P = 0.11, RPc P = 0.7). There was no difference in RFS of receptor positive and negative tumours when the axillary node status was taken into account.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849801      PMCID: PMC2011376          DOI: 10.1038/bjc.1983.101

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  46 in total

1.  Malignant and benign human mammary disease: estrogen binding in relation to clinical data.

Authors:  L Terenius; H Johansson; A Rimsten; L Thorén
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

2.  Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans.

Authors:  J L Wittliff; R Hilf; W F Brooks; E D Savlov; T C Hall; R A Orlando
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

3.  Estrogen receptors in human breast cancer.

Authors:  G Leclercq; J C Heuson; R Schoenfeld; W H Mattheiem; H J Tagnon
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

4.  Human mammary carcinoma studied for hormone responsiveness in short term incubations.

Authors:  K Aspegren; L Håkansson
Journal:  Acta Chir Scand       Date:  1974

5.  Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes.

Authors:  C C Say; W L Donegan
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

6.  The prognostic significance of elastosis in breast carcinoma.

Authors:  A A Shivas; J G Douglas
Journal:  J R Coll Surg Edinb       Date:  1972-09

7.  The in vitro uptake of oestradiol in biopsies from 25 breast cancer patients.

Authors:  S Sander
Journal:  Acta Pathol Microbiol Scand       Date:  1968

8.  The binding of estradiol-17beta to human breast cancers and other tissues in vitro.

Authors:  H Johansson; L Terenius; L Thorén
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

9.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

10.  Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay.

Authors:  P Feherty; G Farrer-Brown; A E Kellie
Journal:  Br J Cancer       Date:  1971-12       Impact factor: 7.640

View more
  19 in total

1.  Correlation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors.

Authors:  Deepti Gupta; Veena Gupta; Nisha Marwah; Meenu Gill; Sumiti Gupta; Gopal Gupta; Promil Jain; Rajeev Sen
Journal:  Iran J Pathol       Date:  2015

2.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  Oestrogen receptors in mucinous carcinoma of the breast: an immunohistological study using paraffin wax sections.

Authors:  S Shousha; A T Coady; T Stamp; K R James; J Alaghband-Zadeh
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

4.  Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.

Authors:  J M Raemaekers; L V Beex; A J Koenders; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 5.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

6.  Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.

Authors:  J S Meyer; M Province
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

7.  Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.

Authors:  J C van der Linden; J P Baak; J Lindeman; J Hermans; C J Meyer
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

8.  Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer.

Authors:  G Gasparini; F Pozza; R Dittadi; S Meli; S Cazzavillan; P Bevilacqua
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy.

Authors:  J M Raemaekers; L V Beex; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer.

Authors:  W Remmele; M Dietz; F Schmidt; K H Schicketanz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.